Literature DB >> 11793447

Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene.

Alicja M Gruszka-Westwood1, Shayne Atkinson, Brenda M Summersgill, Janet Shipley, Manal O Elnenaei, Paresh Jain, Rifat A Hamoudi, Jaspal S Kaeda, Andrew C Wotherspoon, Estella Matutes, Daniel Catovsky.   

Abstract

We describe a case of leukemic mantle cell lymphoma (MCL) with complex karyotype and amplification of the CCND1/IGH fusion gene. Testing for the presence of t(11;14), the hallmark of MCL, revealed multiple copies of the fusion signals. We therefore conducted extensive molecular cytogenetic studies to delineate the nature and consequences of such an abnormality. We localized the amplification to the der(14)t(11;14) and to a der(2) chromosome in a form of interspersed chromosome 11 and 14 material. This resulted in high expression of cyclin D1 mRNA and the protein expressed independently of the cell cycle phase. CGH analysis revealed that the overrepresentation on chromosome 11 included chromosomal band 11q23 in addition to the CCND1 locus at 11q13. The band 11q23 harbors the ataxia telangiectasia mutated (ATM) gene recently proposed to be involved in the pathogenesis of MCL with high incidence of deletions in this locus. Using YAC 801e11, containing the ATM gene, we demonstrated several hybridization signals, suggesting that this region also formed part of the amplicon. This case also showed TP53 gene abnormalities: protein expression, monoallelic deletion, and a mutation in exon 5. The clinical course was aggressive, and the patient died within 6 months of presentation. This is to our knowledge the first description of amplification of the CCND1/IGH fusion gene in a human neoplasm, which may have played a role in the fulminating course of the disease in this patient. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793447     DOI: 10.1002/gcc.1216

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry.

Authors:  P Jain; G M Giustolisi; S Atkinson; M O Elnenaei; R Morilla; K Owusu-Ankomah; F Rafiq-Mohammed; E Matutes; A Wotherspoon; D Catovsky
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.

Authors:  Sílvia Beà; Virginia Amador
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

3.  Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.

Authors:  Sílvia Beà; Itziar Salaverria; Lluís Armengol; Magda Pinyol; Verónica Fernández; Elena M Hartmann; Pedro Jares; Virginia Amador; Luís Hernández; Alba Navarro; German Ott; Andreas Rosenwald; Xavier Estivill; Elias Campo
Journal:  Blood       Date:  2008-11-04       Impact factor: 22.113

4.  Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization.

Authors:  Norihiko Kawamata; Ling Zhang; Seishi Ogawa; Yasuhito Nannya; Azadeh Dashti; Daning Lu; Stephen Lim; Rhona Schreck; H Phillip Koeffler
Journal:  Leuk Res       Date:  2008-09-16       Impact factor: 3.156

5.  Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.

Authors:  Norihiko Kawamata; Seishi Ogawa; Saskia Gueller; Samuel H Ross; Thien Huynh; John Chen; Andrew Chang; Shayan Nabavi-Nouis; Nairi Megrabian; Reiner Siebert; Jose A Martinez-Climent; H Phillip Koeffler
Journal:  Exp Hematol       Date:  2009-05-27       Impact factor: 3.084

6.  Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms.

Authors:  Robert Albero; Anna Enjuanes; Santiago Demajo; Giancarlo Castellano; Magda Pinyol; Noelia García; Cristina Capdevila; Guillem Clot; Helena Suárez-Cisneros; Mariko Shimada; Kennosuke Karube; Mónica López-Guerra; Dolors Colomer; Sílvia Beà; José Ignacio Martin-Subero; Elías Campo; Pedro Jares
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

7.  A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma.

Authors:  Elias Campo; Pedro Jares; Santiago Demajo; Robert Albero; Guillem Clot; Giancarlo Castellano; Alba Navarro; Cristina Capdevila; Anna Enjuanes; Ferran Nadeu; Eva Giné; Magda Pinyol; Elaine S Jaffe; German Ott; Louis M Staudt; Andreas Rosenwald; David W Scott; Lisa M Rimsza; Armando López-Guillermo; Sílvia Beà
Journal:  Clin Cancer Res       Date:  2020-10-12       Impact factor: 13.801

8.  Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.

Authors:  Eniko Papp; Dorothy Hallberg; Gottfried E Konecny; Daniel C Bruhm; Vilmos Adleff; Michaël Noë; Ioannis Kagiampakis; Doreen Palsgrove; Dylan Conklin; Yasuto Kinose; James R White; Michael F Press; Ronny Drapkin; Hariharan Easwaran; Stephen B Baylin; Dennis Slamon; Victor E Velculescu; Robert B Scharpf
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

9.  Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.

Authors:  Joanna C Dalland; James B Smadbeck; Neeraj Sharma; Reid G Meyer; Kathryn E Pearce; Patricia T Greipp; Jess F Peterson; Shaji Kumar; Rhett P Ketterling; Rebecca L King; Linda B Baughn
Journal:  Genes Chromosomes Cancer       Date:  2021-06-22       Impact factor: 5.006

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.